首页> 中文期刊> 《现代肿瘤医学》 >肾嫌色细胞癌的诊断和治疗

肾嫌色细胞癌的诊断和治疗

         

摘要

目的:探讨肾嫌色细胞癌(renal chromophobe cell carcinoma,RCCC)的临床特征、病理学特点、诊断、治疗方法和预后。方法:回顾性分析2010年2月至2015年4月期间经病理检查证实的11例 RCCC 患者的临床资料,结合相关文献复习并进行讨论。结果:11例患者中7例男性,4例女性,年龄40~71岁,平均59岁。肿物直径3.5~14.5cm。病变位于右侧者6例,左侧5例。术前无症状者6例,单纯性腰背部疼痛不适5例。11例患者均经 CT 检查确诊,均行手术治疗。手术过程顺利,术后均有病理证实为肾嫌色细胞癌。出院后随访3~36个月,无肿瘤复发和转移。结论:RCCC 是一种低度恶性,少见的肾脏肿瘤。手术治疗是首选方法,预后较好。%Objective:To investigate the clinical features,pathological characteristics,diagnosis,treatment and prognosis of renal chromophobe cell carcinoma(RCCC).Methods:Clinical data of 11 cases of RCCC were analyzed retrospectively and pertinent literatures were reviewed.Results:Seven cases were males and 4 cases were females, aged 40 ~71,averaged 59 years old.Bump diameter 3.5 ~14.5cm.6 cases were on the right kidney and the other ca-ses were on the left side.6 cases had no symptoms,5 cases complained about simple backache.11 cases were all taken CT scan for diagnosis and undertaken open or laparoscopic surgery.During 3 to 36 months follow -up,no tumor re-lapse.Conclusion:RCCC is a low grade rare renal tumor and the treatment mainly depends on the surgery.Surgery was the preferred method of treatment,and the prognosis is good.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号